Skip to main content
SpringerLink
Log in

Evaluating AVID, CASH, CIDS, CABG-Patch & MADIT: Are They Concordant?

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik S, Fischell RE, Weisfeldt M. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322–324.

    Google Scholar 

  2. Block M, Breithardt G. Long-term follow-up and clinical results of implantable cardioverter-defibrillators. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: W.B. Saunders Company, 1995:1412–1425.

    Google Scholar 

  3. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990;16: 381–386.

    Google Scholar 

  4. Mirowski M, Reid PR, Winkle RA, Mower MM, Watkins L, Stinson EB, Griffith LSC, Kallman CH, Weisfeldt ML. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983;98:585–588.

    Google Scholar 

  5. Furman S. AICD benefit. Pacing Clin Electrophysiol 1989; 12:399–400.

    Google Scholar 

  6. Kim SG, Fisher JD, Furman S, Choue CW, Gross J, Zilo P, Roth JA, Ferrick KJ, Brodman R. Are the benefits of implantable cardioverter/defibrillators overestimated? Cardiol Board Rev 1992;9:76–82.

    Google Scholar 

  7. Fogoros RN. The implantable defibrillator backlash. Am J Cardiol 1991;67:1424–1427.

    Google Scholar 

  8. Böcker D, Block M, Isbruch F, Wietholt D, Hammel D, Borggrefe M, Breithardt G. Do patients with an implantable defibrillator live longer? J Am Coll Cardiol 1993;21: 1638–1644.

    Google Scholar 

  9. Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JN. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083–1092.

    Google Scholar 

  10. Newman D, Sauve MJ, Herre J, Langberg JJ, Lee MA, Titus C, Franklin J, Scheinman MM, Griffin JC. Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992;69:899–903.

    Google Scholar 

  11. Böcker D, Haverkamp W, Block M, Hammel D, Borggrefe M, Breithardt G. Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation 1996;94:151–157.

    Google Scholar 

  12. Wever EF, Hauer RNW, Van Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, Wiesfeld ACP, Bakker PFA, Robles de Medina EO. Randomized study of implantable defibrillator as first-choice therapy versus conventional postinfarct sudden death survivors. Circulation 1995;91:2195–2203.

    Google Scholar 

  13. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, MADIT Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933–1940.

    Google Scholar 

  14. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmicdrug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576–1583.

    Google Scholar 

  15. Kuck KH. ACC NewsOnline: CASH. 1998.

  16. Connolly SJ. ACC NewsOnline: CIDS. 1998.

  17. Bigger JT Jr, Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569–1575.

    Google Scholar 

  18. Anderson JL, Hallstrom AP, Epstein AE, Pinski SL, Rosenberg Y, Nora MO, Chilson DA, Cannom DS, Moore R, The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. Circulation 1999;99:1692–1699.

    Google Scholar 

  19. Siebels J, Cappato R, Ruppel R, Schneider MAE, Kuck KH, the CASH Investigators. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). Am J Cardiol 1993;72: 109F-113F.

    Google Scholar 

  20. Moss AJ, Akiyama T, Cannom DS, Fogoros RN, Gallagher J, Griffin JC, Guarnieri T, Hall WJ, Horowitz L, Klein H, Lehmann MH, Levine JH, Maloney JD, Marcus FI, McAnulty JH, Myerburg R, Platia E, Pratt C, Quatromani A, et al. Multicenter automatic defibrillator implantation trial (MADIT): Design and clinical protocol. Pacing Clin Electrophysiol 1991;14:920–927.

    Google Scholar 

  21. Buxton AE. MUSTT. Multicenter Unsustained Tachycardia Trial. ACC News Online 1999.

  22. Cannom DS, Kay GL, Bhandari AK, Jones MJ, Firth B, Winkle RA, Gaudiani V, Buch W, Fujii J, Singer I, Slater AD, Kupersmith J, Austin EHIII, Pollock S, Stavens CS, Springer MJ, Szabo TS, Adams L, Bigger JT Jr, et al. The Coronary Artery Bypass Graft (CABG) Patch Trial. Prog Cardiovasc Dis 1993;36:97–114.

    Google Scholar 

  23. Curtis AB, Cannom DS, Bigger JT Jr, DiMarco JP, Estes NA, Steinman RC, Parides MK. Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial. Am Heart J 1997;134:787–798.

    Google Scholar 

  24. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Evaluating AVID, CASH, CIDS, CABG-Patch & MADIT 107 Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493–498.

    Google Scholar 

  25. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77–82.

    Google Scholar 

  26. Cairns JA, Connolly SJ, Roberts R, Gent M, the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349: 675–682.

    Google Scholar 

  27. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667–674.

    Google Scholar 

  28. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417–1424.

    Google Scholar 

  29. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TBJ, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ, Ritchie JL, Gibbons RJ, Eagle KA, Gardner TJ, Lewis RP, O'Rourke RA, Ryan TJ, Garson AJ. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175–1209.

    Google Scholar 

  30. Sarter BH, Finkle JK, Gerszten RE, Buxton AE. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol 1996;28: 122–129.

    Google Scholar 

  31. Kuck KH. Prospective studies assessing prophylactic therapy in high risk patients: The German Dilated Cardio-Myopathy Study (GDCMS)-Study design. Pacing Clin Electrophysiol 1992;15:697–700.

    Google Scholar 

  32. Kuck KH, CAT-Investigators. Ein-Jahres-Mortalität bei Patienten mit dilatativer Kardiomyopathie und implantiertem Kardioverter/Defibrillator: CAT, eine randomisierte, kontrollierte klinische Studie. Zeitschrift für Kardiologie 1998;87[Suppl 1], 207.

    Google Scholar 

  33. Nisam S, Mower M. ICD trials: An extraordinary means of determining patient risk? Pacing Clin Electrophysiol 1998; 21:1341–1346.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology and Angiology, and Institute for Arteriosclerosis Research, Hospital of the Westfälische Wilhelms-University, Münster, Germany

    Dirk Böcker & Günter Breithardt

Authors
  1. Dirk Böcker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Günter Breithardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Böcker, D., Breithardt, G. Evaluating AVID, CASH, CIDS, CABG-Patch & MADIT: Are They Concordant?. J Interv Card Electrophysiol 4 (Suppl 1), 103–108 (2000). https://doi.org/10.1023/A:1009838801283

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009838801283

Search

Navigation